Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Contact information

Email
Daniel.Jenkin@ndm.ox.ac.uk

ORCID
https://orcid.org/0000-0003-3088-310X

Research groups

Daniel Jenkin

MBChB, MSc, DTM&H, MRCP

Clinical Research Fellow

Websites

Research Gate Profile

Recent publications

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Journal article

Feng S. et al, (2021), Nature Medicine, 27, 2032 - 2040
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
Journal article

Flaxman A. et al, (2021), The Lancet, 398, 981 - 990
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Journal article

Barrett JR. et al, (2021), Nature Medicine, 27, 1113 - 1113
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Journal article

Ewer KJ. et al, (2021), Nature Medicine, 27, 1116 - 1116
Safety and Immunogenicity of the ChAdox1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 in HIV Infection
Frater J. et al, (2021)

More publications